INVESTIGATION OF THE REASONS FOR THE EMPLOYEE TURNOVER OF PARKINSON'S PATIENTS
Abstract
Keywords
Kaynakça
- 1. Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 Suppl 4): S1-136.
- 2. Grosset DG, Macphee GJ, Nairn M, Guideline Development G. Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines. BMJ. 2010;340: b5614.
- 3. Gershanik OS. Clinical problems in late-stage Parkinson's disease. J Neurol. 2010;257(Suppl 2): S288-91.
- 4. Wickremaratchi MM, Perera D, O'Loghlen C, Sastry D, Morgan E, Jones A, et al. Prevalence and age of onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry. 2009;80(7):805-7.
- 5. Martikainen KK, Luukkaala TH, Marttila RJ. Parkinson's disease and working capacity. Mov Disord. 2006;21(12):2187-91.
- 6. Koerts J, Konig M, Tucha L, Tucha O. Working capacity of patients with Parkinson's disease - A systematic review. Parkinsonism Relat Disord. 2016; 27:9-24.
- 7. Schrag A, Banks P. Time of loss of employment in Parkinson's disease. Mov Disord. 2006;21(11):1839-43.
- 8. Murphy R, Tubridy N, Kevelighan H, O'Riordan S. Parkinson's disease: how is employment affected? Ir J Med Sci. 2013;182(3):415-9.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yazarlar
Gamze Ertürk
*
0000-0002-5038-9005
Türkiye
Semra Oğuz
0000-0002-7148-4562
Türkiye
Mine Gülden Polat
0000-0002-9705-9740
Türkiye
Sibel Ertan
Bu kişi benim
0000-0003-1339-243X
Türkiye
Yayımlanma Tarihi
20 Ağustos 2022
Gönderilme Tarihi
9 Ekim 2021
Kabul Tarihi
9 Mayıs 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 33 Sayı: 2